Abstract
Voclosporin, a more potent derivative of cyclosporine, has been studied extensively in patients with immunologic disorders such as psoriasis, organ transplantation, uvetitis and lupus nephritis. Although better tolerated and safer than cyclosporine, voclosporin is inferior to cyclosporine in treating psoriasis, non-inferior to tacrolimus in organ transplantation and efficacious in treating lupus nephritis. The pharmacokinetic dispositions of voclosporin and cyclosporine in central and peripheral compartments were analyzed and correlated with their distinct clinical efficacy and safety profiles. Both drugs demonstrated non-linear pharmacokinetics with increasing doses, more prominently at lower doses of voclosporin than at 10-fold higher doses of cyclosporine. Repeated lower dosing of voclosporin produced preferential calcineurin inhibition in and near blood circulation, leading to relatively lower cardiovascular and renal adverse effects but inferior efficacy for psoriasis compared to cyclosporine. With 10-fold higher plasma levels and deeper tissue penetration, cyclosporine has more prevalent renal and cardiac toxicities but superior efficacy to treat psoriasis. Although the two drugs are similar in structure and mechanism of ...Continue Reading
References
Aug 1, 1988·Journal of Pharmacokinetics and Biopharmaceutics·J P ReymondW Niederberger
Mar 1, 1986·Clinical Pharmacokinetics·R J PtachcinskiG J Burckart
Nov 1, 1986·Journal of Clinical Pharmacology·G J BurckartD H Van Thiel
May 27, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Pamala A JacobsonRichard Brundage
Jul 9, 2005·Transplantation·Lynda FrassettoLeslie Z Benet
Apr 22, 2008·Lancet·K PappW P Maksymowych
Sep 16, 2008·Lancet·Poobalan Naidoo, Virendra Rambiritch
Aug 12, 2009·Clinical Ophthalmology·Eddy AngladeSidney L Weiss
Sep 29, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S BusqueUNKNOWN PROMISE Investigators
Jun 6, 2013·Journal of Clinical Pharmacology·Patrick R MayoRobert T Foster
Aug 29, 2013·TheScientificWorldJournal·M D ColomboG A Vena
Sep 3, 2013·Journal of Clinical Pharmacology·S Y LingR T Foster
Sep 13, 2013·The AAPS Journal·Michel TodFrançois Gueyffier
Dec 10, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jamil R AzziSamir G Mallat
Apr 22, 2015·Clinical Drug Investigation·Marc BifanoRichard J Bertz
Mar 1, 2013·Turkish Journal of Urology·Ozan EkmekçioğluZeki Ender Güneş
Jun 9, 2016·Clinical Pharmacology in Drug Development·Andreas H GrollRobert Townsend